Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
Clinical trial NCT01101100 · TERMINATED
Trial details
- NCT number
- NCT01101100
- Sponsor
- Bausch Health Americas, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.